Avaleht › 2. tüüpi diabeet › Texas › Houston
2. tüüpi diabeet kliinilised uuringud linnas Houston, TX
31 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid linnas Houston ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Värbamine
- Houston Methodist, Houston
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
VärbamineFaas 2
- Cardiovascular Specialists of Willowbrook, Houston
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
VärbamineFaas 3
- JCCT- Juno NW Houston, Houston
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
VärbamineFaas 3
- Victorium Clinical Research, Houston
- Houston Research Institute, Houston
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
VärbamineFaas 3
- Juno Research, LLC, Houston
- Biopharma Informatic, Inc. Research Center, Houston
- Research Physicians Network, Houston
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
VärbamineTerved vabatahtlikud oodatud
- Helium Research Group, Houston
- Kelsey Research Foundation, Houston
- The Methodist Hospital, DeBakey Cardiology Associates, Houston
- ja veel 1
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
VärbamineFaas 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Houston
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
VärbamineFaas 3
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
VärbamineFaas 3
- Research Site, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
VärbamineFaas 3
- AURORA-2 Clinical Site, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
VärbamineFaas 3
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
VärbamineFaas 2
- Juno Research, Houston
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
VärbamineFaas 2
- JCCT- Juno NW Houston, Houston
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
VärbamineFaas 2
- Juno Research, LLC, Houston
- Prolato Research LLC, Houston
- Clinical Trial Network, LLC, Houston
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
VärbamineFaas 2
- Private Practice - Dr. Laila A. Hassan, Houston
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
VärbamineFaas 2
- Juno Research, LLC, Houston
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
VärbamineFaas 3
- Amir Ali Hassan, MD, PA, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
VärbamineFaas 2
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
VärbamineFaas 3
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi kaugusel
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
VärbamineFaas 3
- PrimeCare Medical Group, Houston
- JCCT- Juno NW Houston, Houston
- Biopharma Informatic_Houston, Houston
- ja veel 2
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
VärbamineFaas 3
- Texas Childrens Hospital, Houston
- UT Health Houston, Houston
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
VärbamineFaas 3
- Research Site, Houston
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Värbamine
- Baylor College of Medicine, Houston
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
VärbamineTerved vabatahtlikud oodatudOsalejatele makstakse tasu
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
CGM for Management of Type 2 Diabetes in Pregnancy
Värbamine
- University of Texas Health Science Center at Houston, Houston
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
VärbamineFaas 2
- Synergy Group Medical, Houston
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
VärbamineVaatlusuuring
- Baylor College of Medicine / Texas Children's, Houston
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Lilli Health, Houston
RESET System Pivotal Trial (Rev F)
Värbamine
- Baylor College of Medicine, Houston
2. tüüpi diabeet uuringud teistes linnades
- San Antonio, TX37 uuringut
- Orlando, FL24 uuringut
- Boston, MA20 uuringut
- Miami, FL19 uuringut
- Chicago, IL19 uuringut
- Dallas, TX19 uuringut
- Columbus, OH18 uuringut
- Las Vegas, NV18 uuringut
- Atlanta, GA17 uuringut
- San Diego, CA17 uuringut
- Los Angeles, CA16 uuringut
- New York City, NY16 uuringut
Muud uuringud linnas Houston
- Mitteväikerakuline kopsuvähk145 uuringut
- Rinnavähk126 uuringut
- Vähk (kõik liigid)121 uuringut
- Metastaatiline vähk104 uuringut
- Käär- ja pärasoolevähk102 uuringut
- Munasarjavähk89 uuringut
- Äge müeloidne leukeemia85 uuringut
- Kopsuvähk78 uuringut
- Eesnäärmevähk76 uuringut
- Endomeetriumivähk68 uuringut
- Pankreasevähk61 uuringut
- Melanoom59 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.